Protagenic Therapeutics, Inc.\new (PTIX) Convertible Debt (2019 - 2023)
Protagenic Therapeutics, Inc.\new (PTIX) reported Convertible Debt of $230,000 for fiscal Q3 2023 (quarter ended Sep 30, 2023), up 81.1% from $127,025 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Convertible Debt (2019 - 2023) Analysis & Trends
Dating back to fiscal Q4 2019, Protagenic Therapeutics, Inc.\new's Convertible Debt record includes 16 quarters.
- Convertible Debt has a three-year compound annual growth rate of 9.6% (FY2019 to FY2022).
- By fiscal year, Convertible Debt came in at $132,284 in FY2021 (-87.8%), $1.08 million in FY2020 (+518.6%) and $174,821 in FY2019.
- Five-year quarterly Convertible Debt spans a low of $103,458 in fiscal Q2 2022 and a high of $1.13 million in fiscal Q1 2021.
- Year over year, Convertible Debt has now increased in each of the last four quarters, with growth averaging 9.0% over the last eight quarters.
- The high point for year-over-year Convertible Debt in five years was fiscal Q4 2020 (growth of 518.6%); the low point was fiscal Q1 2022 (a decline of 90.5%).
- Per Business Quant data, the three fiscal quarters before Q3 2023 came in at $230,000 (Q2 2023), $230,000 (Q1 2023) and $230,000 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.36 Mn | 1.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 230,000.00 |
| Jun 30, 2023 | 230,000.00 |
| Mar 31, 2023 | 230,000.00 |
| Dec 31, 2022 | 230,000.00 |
| Sep 30, 2022 | 127,025.00 |
| Jun 30, 2022 | 103,458.00 |
| Mar 31, 2022 | 107,065.00 |
| Dec 31, 2021 | 132,284.00 |
| Sep 30, 2021 | 441,435.00 |
| Jun 30, 2021 | 350,279.00 |
| Mar 31, 2021 | 1.13 Mn |
| Dec 31, 2020 | 1.08 Mn |
| Sep 30, 2020 | 1.03 Mn |
| Jun 30, 2020 | 960,711.00 |
| Mar 31, 2020 | 433,560.00 |
| Dec 31, 2019 | 174,821.00 |
API Access
Protagenic Therapeutics, Inc.\new Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();